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Background: The development of a clinically significant paravalvular leak is an uncommon, but serious complication of valve surgery. 
Percutaneous device closure has emerged as an alternative to surgical treatment. This study will evaluate the efficacy and safety of 
percutaneous device closure within a single centre.
methods: This study design is a retrospective evaluation of 15 percutaneous device closures (3 aortic, 12 mitral) performed on 14 patients 
(9 female, mean age 65 ± 11.5, mean BMI 29.9, mean contrast used 41mL) between February 2008 and May 2014. We analysed the 
clinical and echocardiographic findings of these patients in the pre and post-closure period using a paired t-test scoring method.
results: The device was successfully implanted in 87% of patients. Device placement significantly improved functional class and reduced 
the degree of regurgitation. The mean NYHA class pre-procedure was 2.75 (95% confidence interval [CI], 2.36 to 3.14) and post-procedure 
was class 2.15 (95% CI, 1.56 to 2.73), p value = 0.0239. The mean grade of paravalvular mitral regurgitation (MR) was 2.9 (95% CI, 2.43 
to 3.38) prior to the procedure, reducing to a mean grade of MR of 1.08 post-procedure (95% CI, 0.295 to 1.77), p valve = 0.0008. The 
survival rate was 93% at 90 days. One patient suffered a procedure related myocardial infarction.
conclusion:  Percutaneous device closure for the treatment of paravalvular leaks is a safe procedure that significantly improves patient 
symptoms and degree of regurgitation at follow up.
